| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/25/2004 | WO2002102399A3 Mucosal repair by tff2 peptides |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | WO2002044342A3 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 03/25/2004 | WO2002002095B1 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
| 03/25/2004 | US20040059144 Aspirin-triggered lipid mediators |
| 03/25/2004 | US20040059130 Benz(f)indole compounds useful for Inflammatory Diseases |
| 03/25/2004 | US20040059113 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 03/25/2004 | US20040059110 Such as N,N'-bis(2-hydroxybenzyl)-L-cystine |
| 03/25/2004 | US20040059107 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; pharmaceutical formulations, improved cell and organ culture media, cryopreservation media, antiaging, chemoprotective and radioprotective uses |
| 03/25/2004 | US20040058968 Antiinflammatory agents; autoimmune diseases; antiarthritic agents |
| 03/25/2004 | US20040058964 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 03/25/2004 | US20040058963 Cardiovascular disorders; hypotensive agents; antiallergens; antihistamines; antiarthritic agents; skin disorders |
| 03/25/2004 | US20040058961 Antiallergens; antihistamines; autoimmune diseases; anticholesterol agents; cardiovascular diseases |
| 03/25/2004 | US20040058960 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 03/25/2004 | US20040058940 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058925 Method of treating fibromyalgia and other somatoform disorders |
| 03/25/2004 | US20040058923 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 03/25/2004 | US20040058922 Tyrosine inhibitor; immunosuppressants; antiarthritic agents; autoimmune diseases; antiproliferative agent |
| 03/25/2004 | US20040058916 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 03/25/2004 | US20040058914 Combination drugs |
| 03/25/2004 | US20040058913 Cyclic diamine compound with condensed-ring groups |
| 03/25/2004 | US20040058907 Compounds useful in the treatment of inflammatory diseases |
| 03/25/2004 | US20040058904 Antiinflammatory agents; autoimmune disease |
| 03/25/2004 | US20040058901 Crystalline ethanolate solvate form of zafirluskast process for manufacture and pharmaceutical compositions thereof |
| 03/25/2004 | US20040058850 Using caspase inhibitor; antiinflammatory agents |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | US20040057965 Compositions and methods for treatment of mucosal infections |
| 03/25/2004 | US20040057943 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 03/25/2004 | US20040057905 Nanoparticulate beclomethasone dipropionate compositions |
| 03/25/2004 | CA2502583A1 Isoquinoline derivatives having kinase inhibitory activity and medicament containing the same |
| 03/25/2004 | CA2498911A1 Tiotropium salts for reducing respiratory mortality rate |
| 03/25/2004 | CA2498045A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 03/25/2004 | CA2497550A1 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 03/25/2004 | CA2497067A1 Amino-propanol derivatives |
| 03/25/2004 | CA2494274A1 Method and composition for regulating the activity of regulatory t cells |
| 03/24/2004 | EP1400521A1 Piperazine compounds |
| 03/24/2004 | EP1400519A1 Respiratory syncytial virus replication inhibitors |
| 03/24/2004 | EP1400518A1 Heterocyclic compound derivatives and medicines |
| 03/24/2004 | EP1400515A1 Cyclic diamine compound having five-membered cyclic group |
| 03/24/2004 | EP1400513A1 Unsymmetrical cyclic diamine compound |
| 03/24/2004 | EP1400510A1 Cyclic diamine compounds having fused-ring groups |
| 03/24/2004 | EP1399563A2 Moraxella (branhamella) catarrhalis antigens |
| 03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
| 03/24/2004 | EP1399548A2 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 03/24/2004 | EP1399479A2 Cation conducting gaba a receptors and their use |
| 03/24/2004 | EP1399472A2 Soluble heterodimeric cytokine receptor |
| 03/24/2004 | EP1399447A1 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases |
| 03/24/2004 | EP1399441A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/24/2004 | EP1399440A1 5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors |
| 03/24/2004 | EP1399439A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 03/24/2004 | EP1399435A2 Pyridine derivatives useful as cd40:cd154 binding interruptors and use thereof to treat immunological complications |
| 03/24/2004 | EP1399432A1 Spiropiperidine compounds as ligands for orl-1 receptor |
| 03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 03/24/2004 | EP1399420A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399419A1 New compounds useful in reflux disease |
| 03/24/2004 | EP1399215A2 Tissue-specific endothelial membrane proteins |
| 03/24/2004 | EP1399155A2 Small molecules useful in the treatment of inflammatory disease |
| 03/24/2004 | EP1399147A2 Therapeutic delivery of carbon monoxide |
| 03/24/2004 | EP1399137A1 Sulfonamides |
| 03/24/2004 | EP1399127A1 Olopatadine formulations for topical administration |
| 03/24/2004 | EP1399105A2 Method for cleaning hard gelatine capsules |
| 03/24/2004 | EP1252164B1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 03/24/2004 | EP1161232B1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 03/24/2004 | EP1124809B1 Benzoylpyridazines |
| 03/24/2004 | EP1045695B1 Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f 1? to treat peripheral vascular disease |
| 03/24/2004 | EP0922036B1 Arylalkanoyl pyridazines |
| 03/24/2004 | EP0777494B1 Human chemokine polypeptides |
| 03/24/2004 | CN1484652A Antibodies to human IL-1 beta |
| 03/24/2004 | CN1484644A Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/24/2004 | CN1483478A Eye preparation formula adapted for therapentic medicine |
| 03/24/2004 | CN1483475A Combined bacterin for treating allergic disease and preparation method |
| 03/24/2004 | CN1483464A Traditional Chinese herbal medicine for treating laryngotracheitis of domestic fowl |
| 03/24/2004 | CN1483463A Anti-virus Chinese medicine composition and preparation process thereof |
| 03/24/2004 | CN1483435A Medicine for treating throat disease |
| 03/24/2004 | CN1142996C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 03/24/2004 | CN1142918C Carboxylic acid derivs, their preparation and their use |
| 03/24/2004 | CN1142912C Amide derivs, useful as inhibitors for production of cytokines |
| 03/24/2004 | CN1142788C Chinese medicine preparation for treating infant pulmonitis and dyspneic cough |
| 03/24/2004 | CN1142781C Use of 9-deoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'- interphenylene)-13,14-dihydro-prostaglandin F, to treat peripheral vascular disease |
| 03/24/2004 | CN1142770C Process for production of powdered pulmoney surfactant preparations |
| 03/23/2004 | US6710165 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects |
| 03/23/2004 | US6710080 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 03/23/2004 | US6710067 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/23/2004 | US6710061 Selective serine protease or dual-serine protease inhibitors of factor xa and tryptase |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/23/2004 | US6709676 Bilayer solid comprising an immediate release first layer of desloratadine, and an antioxidant or group 2a or aluminum salts and excipient, and a sustained release second layer of nasal decongestant such as pseudoephedrine sulfate |
| 03/23/2004 | US6709671 Water soluble film for oral administration with instant wettability |
| 03/23/2004 | CA2350074C Aerosols comprising nanoparticle drugs |
| 03/23/2004 | CA2168432C Piperazine compounds used in therapy |
| 03/18/2004 | WO2004022761A1 Retroviral vector and stable packaging cell lines |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022582A1 Peptidomimetic drugs |
| 03/18/2004 | WO2004022569A1 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 03/18/2004 | WO2004022557A1 Novel benzonaphthyridines |
| 03/18/2004 | WO2004022553A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE |
| 03/18/2004 | WO2004022547A1 Phenethanolamine derivatives and their use in the treatment of respiratory diseases |
| 03/18/2004 | WO2004022536A1 New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 03/18/2004 | WO2004022535A1 Acrylamide derivatives |